Guggenheim Capital’s Sinovac Biotech, Ltd SVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-20,840
| Closed | -$179K | – | 2820 |
|
|
2018
Q1 | $179K | Sell |
20,840
-1,059
| -5% | -$9.1K | ﹤0.01% | 2630 |
|
|
2017
Q4 | $173K | Buy |
21,899
+3,517
| +19% | +$27.8K | ﹤0.01% | 2582 |
|
|
2017
Q3 | $129K | Buy |
18,382
+91
| +0.5% | +$639 | ﹤0.01% | 2641 |
|
|
2017
Q2 | $123K | Sell |
18,291
-459
| -2% | -$3.09K | ﹤0.01% | 2683 |
|
|
2017
Q1 | $107K | Sell |
18,750
-2,676
| -12% | -$15.3K | ﹤0.01% | 2689 |
|
|
2016
Q4 | $126K | Sell |
21,426
-3,329
| -13% | -$19.6K | ﹤0.01% | 2751 |
|
|
2016
Q3 | $146K | Buy |
24,755
+37
| +0.1% | +$218 | ﹤0.01% | 2697 |
|
|
2016
Q2 | $147K | Sell |
24,718
-1,672
| -6% | -$9.94K | ﹤0.01% | 2704 |
|
|
2016
Q1 | $169K | Sell |
26,390
-2,798
| -10% | -$17.9K | ﹤0.01% | 2707 |
|
|
2015
Q4 | $167K | Buy |
+29,188
| New | +$167K | ﹤0.01% | 2791 |
|